<DOC>
	<DOCNO>NCT02413398</DOCNO>
	<brief_summary>The purpose clinical research study determine whether dapagliflozin improve ( decrease ) blood glucose value patient Type 2 diabetes moderate renal impairment.This study conduct approximately 100 centre country across North America European region . It plan randomize total 302 patient .</brief_summary>
	<brief_title>A Study Evaluate Effect Dapagliflozin Blood Glucose Level Renal Safety Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Female male age ≥18 year &lt; 75 year . History T2DM 12 month . Inadequate glycemic control , define HbA1c ≥7.0 % ≤11 % Stable antidiabetic treatment regimen Renal impairment : CKD 3A Women childbearing potential unwilling unable use acceptable method avoid pregnancy entire study period . History diabetic ketoacidosis hyperosmolar nonketotic coma . Severe uncontrolled hypertension define SBP ≥180 mmHg and/or Diastolic Blood Pressure ( DBP ) ≥110 mmHg Any follow Cardiovascular ( CV ) /Vascular Diseases within 3 month prior sign consent visit 1 : Myocardial infarction , Cardiac surgery revascularization ( CABG/PTCA ) , Unstable angina , Unstable heart failure ( HF ) , HF New York Heart Association ( NYHA ) Class IV , Transient ischemic attack ( TIA ) significant cerebrovascular disease , Unstable previously undiagnosed arrhythmia . History biopsy image verify intercurrent kidney disease ( glomerular nephritis sign renal artery stenosis ) diabetic nephropathy diabetic nephropathy nephrosclerosis . Significant hepatic disease , include , limited , chronic active hepatitis and/or severe hepatic insufficiency . Ongoing treatment SGLT2inhibitor , GLP1 analogue , rapid/short act insulin screen . Participation another clinical study Investigational Product ( IP ) last 30 day prior sign consent visit 1 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>